Research & Development

青娱乐视频极品盛宴青娱乐盛宴国产青娱乐极品视觉盛宴av北约秘书长称中国将“快速成为”技术大国

發布時間︰

  “就因為這個?”雲瑯的回答完全出乎了宋喬的預料。   畢竟,你的病沒看好,完全是你人品不好,關醫生屁事。青娱乐视频极品盛宴   “陛下的目標是什麼地方?”青娱乐盛宴国产   “一見傾心?”長平好像在干嘔。   甦稚受夠了,雲家今天的中午飯都沒有著落,她到現在都餓著肚子。青娱乐极品视觉盛宴av   雲瑯咬著牙道︰“不說這事了,你的想法總是跟我起沖突,說說你去匈奴的打算吧,你真的準備嫁給軍臣單于?一輩子伺候一個骯髒的老家伙?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo